Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Which is less important, the share price or the CEO?
. . . Of least importance are the shareholders. . . .
Some would say our beloved maverick of a CEO would
never stoop so low as to pretend to care about us
insignificant shareholders; -That we should remember
our place.. . . If Nasrat is currently developing
anything, it is most likely a neurosis rooted in
guilty indolence.
While you say you have "some background in stock price
prediction", your further comments regarding Elite sound like
you have some background in fortune-telling!
Nasrat could "look good in the eyes of his colleagues" if simply
after the company declared bankruptcy,rendering all retail investment in the company worthless, management could keep their jobs while working under new corporate ownership.
"This baby will explode very soon"
I think Nasrat would definitely disagree. An audio
replay of the conference call has value as a model
of what you hear from a management that is totally
complacent. It is the sound of persons happy not with
the success of the company, but rather with making enough
ambiguous progress to keep current shareholders hoping and
to apparently entice a few as foolhardy today as their predecessors
where over the last decade. Ten years from now how likely is it
someone commenting on a conference call will say, "At least they
are keeping the lights on."?
But here's the thing. . . "Trials start "soon" for the new CNS product.". . . -Do they really? What is meant by "soon"? Every conference call has vague upbeat speculation that does not come to fruition. -We were told there would be no hold-up with API.
Now we hear we are yet again waiting for API.
"Having Nasrat pivot when he did was part luck and part skill but All Guinness!!!!: . . . More like all Stegmaier. . . . The generally accepted belief regarding 'genius' is that it requires indefatigable effort. Also, most anyone can be called a genius. It is what one accomplishes that determines whether they merit such a designation. So far, Nasrat only deserves to be called a genius sarcastically.. . . As in, "Yea. . . Sequestox. . . now that was a real work of genius. . ." In his defense you might point toward the well-known study that indicates smart people frequently take naps.. .
I was wrong. I thought that after stating he would consider himself a "loser" if good results weren't obtained in a timely fashion, Nasrat would make a point to show some initiative, to change things up to gain some traction after the last conference call. Here we are yet again with silence and a share price hovering around $0.06. It has become the norm that on days when the vast majority of stocks are green, ELTP is red. -The potential is there. The management is not.
A mix-up below with "non ELTP shareholders" and "ELTP non shareholders". No matter.. . . Considering Nasrat's calling himself a prospective failure makes me feel much better about him as a CEO. Few arrive at Success without encountering "Failure" in some form. I am cautiously optimistic. My caution deriving from consideration of possible routes to failure, and my optimism deriving from consideration of recent progress and routes to success. Of course, success might be a characteristic of "the journey" rather than "the destination". As such, realizing the challenges which threaten failure can be termed a "success" of sorts.
Actually, after the spike in 2014. . . whenever it was. . . I did find evidence suggesting such an occurrence- By a group out of London no less. In any event, I realize this means nothing without proof. What "proof" I have at this time probably consists of a name scribbled in the margin of a tablet from 2014. If I run across it, I will certainly post it. In the meantime, this would appear to be a good time for such a move as there is a somewhat plausible scenario for accelerated success on the part of Elite going forward.
I think soon a private fund will make a sizeable investment here and subsequently do what they legally can to manipulate the price upwards.
Hey Mikey, I like it! The CC. . . "Nothing up my sleeve. . . "
The problem with that is, "over promise and under deliver"
Whoo-hoo! $6,000,000.
"We can push this to .20+ over time"
"Nothing can stop us!"etc., etc.. . .
-$6,000,000.
Aside: "We can push this to .20+ over time"
That sounds like the reddit, WSB social pump
strategy. -Anyone who has been here awhile has
already been asked to get their neighbors and family
members to buy stock by the resident gurus and a number
of gurus who have just been passing through 'River City'.
This is actually nothing new. In virtually every state their is a constant jockeying for market-share between name-brand and generic manufacturers. Just how low name-brand manufacturers want to price their products, and for how long is the question. Given the historically huge discrepancies in pricing, this is most likely "business as usual" in the overall scheme of things.
$0.0725 Will it be the high for 2021?
This is New Jersey man. You're s'posed to like the CEO for his lack of convictions. There's an area where he can be called a "strategist". . . . Nasrat's "convictions" cause him to consider applying measures consistent with nurturing a small company on the OTCBB as beneath him. Yet ELTP trades on the OTCBB. Hey Nasrat, you're CEO of Elite Pharmaceuticals, not Acme Pharmaceutical.
"Nasrat is a strategist" and it is probable most days he
doesn't even know what the stock price is. Global history
will provide ample examples of "strategists" who lost everything
and then some. "Nasrat is a strategist". . . Pfft! C'mon! Over the top with ya shareholders! Lively now ladies!
Top O' the mornin' to ya elite traders!
Soon Shamus will lead Nasrat to a pot o' gold. Then
it's onward and upward to Dollarland!
Elite is breaking Elite's record. . .
Shareholders should be very concerned about the possible
steps Nasrat and crew might take to up-list in the near future.
The best thing to do at this time would in fact be to postpone the up-listing. Thus, with a good deal of hype an up-lisiting will most likely occur. I can hear it now, "This is an exciting time for Elite Pharmaceuticals!" Of course it is. When one proceeds down a poorly chosen path in a clumsy, careless manner, it is bound to make for some excitement. Vultures live for excitement.
"Do you have facts to support your statement."
Um. . . not to wax professorial, but questions use question-marks.
These are question-marks (???). I realize English may not be your first language.. . . Do I have facts to support the idea that Nasrat took the helm of a small contract manufacturing pharmaceutical company, changed it's direction, taking it down a very long and equally costly path toward something he himself referred to as, "Dollar-land", while repeatedly diluting shareholder value and creating contractual obligations to entities of questionable value?. . . Nope. I don't have any facts. . . just too many shares valued at $0.057.
Adderall never performed as hoped.
. . . There are a lot of folks on these boards who
call themselves "Doctor" so-and-so who actually have no
medical training whatsoever. You certainly sound professorial.
And, as such, so as to bring a fresh perspective to the Elite Shareholder experience, you have coined the term, "Elite shareholder scar-tissue". I don't think we are at the stage where attempts at healing have occurred. I think we are currently in the midst of a good old fashioned New Jersey pharmaceutical company goring courtesy of "Nasrat The Bull" (In a China-shop).
Currently we are in -6.66% Land.. . . Whew!
-That's better, -8.33% Land. -That superstitious
stuff gives me the hee-bee-gee-bees.
I guess this is what, "Say good-bye to the sixes!" means.
"No Worries" is as good a mantra as any under the present circumstances. Shout out to Nasrat for his ceaseless efforts to protect shareholders from the dangers associated with wealth.
You might see $0.04's before the day is over!
Limelight Networks LLNW Hires a new CEO and the share price goes up 15% as the company's future suddenly seems bright. . . Nasrat!. . . Nasrat?. . . Come out come out wherever you are!
The stock has an image problem. . .
with Nasrat being the CEO and all. . .
It don't get no respect. . .
from the street.
Nonsense beyond a doubt. A suitable accompaniment to the recent press release.
Hammer Time- a colloquial expression originally indicating that point in time when conditions are most favorable for absconding. . . . See, "flight to avoid prosecution"
Nasrat has been "going through the motions" of running a company
for some time now. At this point he might as well inform shareholders that there are countless things more enjoyable than making Elite into a successful company.
Posted earlier: "I guess we will just have to "wait and see" what the market thinks of Jason from Rutgers and his current involvement with Elite. . . If any."
-The Market Has Spoken.
Nasrat's house of cards was never meant to be. -At least
not for shareholders. Plenty of people have prospered from
The Nasrat Fiasco, just not shareholders.
If it is in fact the case that Jason M. LePree from Rutgers was previously hired by Elite and no mention of that fact was made in the current announcement, then, while some may see this as a somewhat desperate attempt to show that action is being taken to
move the company out of "it's current rut" (an 8 year rut), this action is about as expected in that while undoubtedly signalling "desperation", it involves no actual "W.O.R.K", and amounts to a poor sort of "sleight of management".
I guess we will just have to "wait and see" what the market thinks
of Jason from Rutgers and his current involvement with Elite. . . If any.
ELTP closed @ $0.0769 1 year ago today. 28% lower for the year.
Nasrat should quit pretending to be CEO.
How many years did Nasrat spend in 8th Grade?
Also, Did he go to Law School with Raul Duke?
-Thanks!. . . (Oops! -That should be, "misspend")
Price Initiatives for 2021
Nasrat has pledged to only wear designer clothing, drink more expensive wines, and stay in 4-star or better hotels for 2021.
After all, "You're only as good as you look!". Right 165 Ludlow Ave., Northvale, New Jersey ?!
As CEO of a small pharmaceutical company located in northern New Jersey, Nasrat is right where he belongs. -Sad but very true that while the OTC markets are notoriously sleazy, the whole pharmaceutical industry, from the multinational giants to small companies like ELITE, is blighted by greed manifesting in countless ways at great cost to society. Arguably, the worst offenders profiting from corruption within the pharmaceutical industry are those government officials tasked with monitoring abuses. Is Nasrat considering a position with the FDA? He would be a great fit. They would like his style. Sometimes you have to cut off the leg to save the body. Sometimes you have to cut off the other leg to make a buck for yourself.
How might I get cost-basis information for current ELTP shareholders
who have held shares for 1 and 1+ 1,2,3... years?. . .
. . . "Depth-sounder"?
"No News Is Good News." Shareholders are due for some news.
Be prepared for an Elite-Mikah sale or partnership arrangement
that while promising blue-skies ahead actually constitutes a total disregard for shareholder interests.
It could be deemed a question of standards. . . or lack thereof. The stock price is down about 80% during Nasrat's tenure. Apparently, -80% is a figure Nasrat can be proud of.
I really don't mean to be "dancing on the bar for nickels" with all my inane chatter. Rather, holding on to a slim hope that somehow, something "in the wind" might reach our MIA CEO that indicates shareholders are dismayed with a company that for all intent and purpose is "mothballed" by managerial complacency. While successful companies are "routinely" seeking new customers, partners, and products, Nasrat and company are routinely over-promising and under-delivering. As if that is O.K..
"A rising tide floats all boats." Upon hearing this, Nasrat Hakim, CEO of Elite Pharmaceuticals remarked, "Arrgh! I fancy me-self a submarine captain, plumbing the depths of the market! I'm puttin' the parrot on the payroll!" Parrot: "Dollarland!. . . Dollarland!"